WASHINGTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/clinicalresearch?src=hash" target="_blank"gt;#clinicalresearchlt;/agt;–The Association
of Clinical Research Organizations (ACRO) is pleased to announce the
expansion of its membership to include ERT,
Oracle
and Veeva.
These new ACRO member companies, with their focus on digital
technologies that enable global clinical trials, characterize the
ongoing innovation and evolution of contemporary clinical research. ACRO
now has 12 member companies.
“Leveraging digital technology in clinical trials is now standard
practice,” said Dr.
Cynthia Verst, President of Global R&D Design and Delivery
Innovation at IQVIA, and Chair
of ACRO’s Board of Directors. “Expanding additional
technology-focused voices into the Association helps us think more
broadly about the future of clinical research. We welcome our three new
members in joining us to continue our mission to accelerate digital
transformation to advance our industry.”
“ACRO’s mission to improve the quality, efficiency and safety of
biomedical research is well aligned with ERT’s,” said James Corrigan,
President and CEO of ERT. “We look forward to joining this group of
leading clinical service providers and contributing to the dialog on how
innovative technologies are advancing clinical research processes and
outcomes.”
“We are excited to join the discussion on how CROs and technology
providers can better work together to improve the clinical trial process
for life sciences companies,” said Henry Levy, General Manager of Veeva
CDMS at Veeva Systems.
With increased membership and new voices from the software and
technology sector, ACRO is eager to expand its collaborations with
stakeholders across the clinical research enterprise.
About ACRO
The Association of Clinical Research Organizations (ACRO) represents
companies that provide a variety of specialized services that support
the development of new pharmaceuticals, biologics and medical devices.
Through its member companies, ACRO helps improve the quality, efficiency
and safety of biomedical research. ACRO member companies employ more
than 130,000 professionals worldwide and conduct or support the vast
majority of clinical trials.
Contacts
Matt Feldman
mfeldman@acrohealth.org